Ultralife Corp risk profile
53 Elevated one input has moved against it
Measured 1 September 2026 from ULBI's filed statements. Recomputed nightly.
53 (Elevated), driven by Leverage and coverage at 83, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 58 | Elevated | Volatile | One-year price volatility — 56.7% |
| Operating pressure | 53 | Elevated | Worsening | Costs outgrowing revenue — +3.4 percentage points |
| Cash conversion | 43 | Elevated | Worsening | Capital spending against operating cash — 0.35x |
| Leverage and coverage | 83 | Acute | Worsening | Net debt to EBITDA — 38.24x |
| Competitive position | 45 | Elevated | Stable | Operating-margin gap against peers — -6.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.